Medical Information Only. Consult your healthcare provider before considering clinical trial enrollment.
Bacterial Vaginosis: full-pipeline trial registry
3 of 16 indexed Bacterial Vaginosis trials are currently recruiting.
Corpus placement: #1,060 of 28,707 conditions by registered trial count.
16 US clinical trials · 3 currently recruiting · #1,060 of 28,707 conditions by registered trial count
Bacterial Vaginosis: 16 US clinical trials tracked, 3 recruiting.
Bacterial Vaginosis is the subject of 16 registered US clinical trials on ClinicalTrials.gov, 3 of them currently open to new participants. 5 are in Phase 3-4 (later-stage) and 5 in Phase 1-2 (earlier-stage). The most active sponsor is National Institute of Allergy and Infectious Diseases (NIAID), running 3 of these trials.
Enrollment posture brief
Registry condition bacterial-vaginosis
OPEN 3 | RECR 19% | LATE 5 | EARLY 5 | RANK #1060 | SPON 3
Volume-matched condition peers
Nearest open-share peer: Myelodysplastic/Myeloproliferative Neoplasms (19% recruiting · 16 trials)
Bacterial Vaginosis lists 3 open slots (19% of 16 indexed trials). Peers are matched on registered volume, not therapeutic-area browse lists. How peer matching works →
Key findings
What ClinicalTrials.gov does not surface for Bacterial Vaginosis on its own pages , computed from the registry mirror as of 2026-08-08. Each line carries its own denominator so it can be quoted as it stands.
-
Bacterial Vaginosis is recruiting below its size-band peers.
3 of 16 indexed trials (18.8%) are open to enrollment, against a 46.5% average across 27,806 conditions with fewer than 20 trials. The peer set uses the same ClinicalTrials.gov-derived counts as this page.
-
One sponsor concentrates Bacterial Vaginosis research.
National Institute of Allergy and Infectious Diseases (NIAID) accounts for 3 of 16 trials (18.8%). 13 distinct sponsors appear on at least one study for this condition label.
-
Typical Bacterial Vaginosis enrolment sits around 234 participants.
Median target enrolment is 234 among the 16 trials that report a genuine target (sentinel values excluded). 6 of those (37.5%) plan for fewer than 100 participants.
-
Bacterial Vaginosis research is mostly interventional.
13 interventional and 3 observational studies make up this index (81.3% interventional). Study type is sponsor-reported on ClinicalTrials.gov.
Open and recent trials
16 total, page 1 of 1
Prospective Data Bank Creation to Study Vaginal Conditions
Texas Tech University Health Sciences Center
NCT01829204
Exploring the Effects of an Intravaginal Lactic Acid Gel on the Vaginal Microbiome
Queen's Medical Center
NCT05753813
Clinical Protocol CERN Feasibility Study
Cern Corporation
NCT06933420
Single Arm Trial of Menstrual Cups Among Economically Vulnerable Women to Reduce Bacterial Vaginosis and STIs
Rush University Medical Center
NCT05666778
Study Evaluating the Equivalence of GDC-229 and Metronidazole Vaginal Gel 0.75% in the Treatment of Bacterial Vaginosis
Balmoral Medical company
NCT03091777
Performance Study of the Cobas® BV/CV Test on Samples From Participants With and Without Symptoms of Bacterial Vaginosis and Candida Vaginitis
Hoffmann-La Roche
NCT06975436
A Multi-center, Double-blind, Randomized Study, Comparing Clindamycin Phosphate Vaginal Cream 2% (Watson Laboratories, Inc.) to Clindesse® (Ther-Rx™, Clindamyin Phosphate Vaginal Cream 2%) and Both Active Treatments to a Placebo Control in the Treatment of Bacterial Vaginosis in Non-pregnant Women
Actavis
NCT02210689
Treatment of Bacterial Vaginosis (BV) With Tinidazole
University of Alabama at Birmingham
NCT00334633
A Validation Study of Genzyme Diagnostics OSOM Trichomonas Rapid Test and BVBlue Test
University of Pittsburgh
NCT00682851
Topical Metronidazole and Miconazole Co-formulated Vaginal Suppositories for Preventing Vaginal Infections in HIV-seronegative Women
National Institute of Allergy and Infectious Diseases (NIAID)
NCT01230814
LACTIN-V Study for Recurrent Bacterial Vaginosis
National Institute of Allergy and Infectious Diseases (NIAID)
NCT02766023
Vitamin D and Sexual Health
Ohio State University
NCT01450462
Effects of a Vaginal Contraceptive Ring on Vaginal Microbiota and Local Immunity
University of Washington
NCT02432404
Suppression Of Bacterial Vaginosis (BV) [SUBVert]
National Institute of Allergy and Infectious Diseases (NIAID)
NCT03930745
Asymptomatic Bacterial Vaginosis and Herpes Simplex Virus Type 2 (BV/HSV-2) Shedding Study
University of Pittsburgh
NCT00464542
Flourish HEC to Prevent Recurrence of BV
Vaginal Biome Science
NCT05386147
Phase Distribution
| Phase | Trial count |
|---|---|
| Phase 1 | 1 |
| Phase 2 | 4 |
| Phase 3 | 2 |
| Phase 4 | 3 |
Top Sponsors
Named interventions
Most-linked intervention names on Bacterial Vaginosis records (sponsor-reported on ClinicalTrials.gov). Counts are trial links, not unique products.
US sites by state
Facility locations filed on Bacterial Vaginosis trials. A trial with sites in several states counts in each.
Source: ClinicalTrials.gov, National Library of Medicine. Data is informational only.
Related
What to do with this Bacterial Vaginosis page
16 registered trials, 3 currently recruiting, is a starting point for a conversation, not a diagnosis or a recommendation.
- 3 Bacterial Vaginosis trials are currently recruiting, check eligibility criteria before contacting a site. Browse recruiting trials
- National Institute of Allergy and Infectious Diseases (NIAID) sponsors the most Bacterial Vaginosis trials on record, review their full trial history before evaluating a specific study. See National Institute of Allergy and Infectious Diseases (NIAID)'s trials
- Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide
Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This Bacterial Vaginosis condition card totals 16 registered trials; most-linked intervention Metronidazole; top US site state Pennsylvania. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.